Performance of Fungitell STAT point-of-care test for the diagnosis of invasive fungal diseases
Medical Mycology · 2025
DOI: 10.1093/mmy/myaf050 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Medical Mycology, 2025. Verfasst von Camille Cordier und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Parasitologie-Mycologie, Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille, 59000 Lille, France. Hauptthemen laut MEDLINE: Invasive Fungal Infections, beta-Glucans, Point-of-Care Testing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Associates of Cape Cod Inc.
Abstract (Originalsprache)
(1→3)-ß-d-glucans (BDG), major cell wall components of most pathogenic fungi, are useful for the diagnosis of invasive fungal diseases (IFD) due to their high negative predictive value. For several years, a number of BDG detection tests are commercially available, including Fungitell Assay (FA) and Wako assay, and more recently Fungitell STAT (STAT) unit test. Our aim was to compare the performance of the two Fungitell assays for IFD diagnosis. Sera from 90 patients with Pneumocystis jirovecii pneumonia (PJP, n = 30), candidemia (n = 30), and invasive pulmonary aspergillosis (IPA, n = 30), 30 patients colonized by P. jirovecii, and 70 healthy controls (women followed-up during pregnancy) were analyzed retrospectively. STAT and FA assays were performed according to manufacturer's instructions. The overall level of agreement between two Fungitell assays was excellent (weighted Cohen's kappa = 0.87 [95% CI: 0.80–0.94]). BDG rates were significantly higher in candidemia, IPA and PJP than in healthy controls (P < .0001). BDG rates were also significantly higher in PJP than for P. jirovecii colonization (P < .0001). Area Under the Curve (AUC) of STAT (0.92) was higher than FA (0.86) for IFD diagnosis. Using optimized positivity thresholds for IFD diagnosis (94 pg/ml and 0.86 for FA and STAT, respectively), sensitivities and specificities were 78.9% and 90% for FA and 85.6% and 88.6% for STAT, respectively. AUC of FA and STAT were higher for PJP diagnosis than for candidemia and IPA diagnosis. Compared to FA, STAT assay represents an interesting option for emergency IFD diagnosis and for small care centers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire de Parasitologie-Mycologie, Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille, 59000 Lille, France.
- Unité de Glycobiologie Structurale et Fonctionnelle (CNRS UMR 8576), INSERM U1285, Université de Lille, 59000 Lille, France.
- Service de Maladies Infectieuses, Centre Hospitalier Universitaire de Lille, 59000 Lille, France.
- U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Université de Lille, 59000 Lille, France.
- Pôle de Médecine Intensive-Réanimation, Centre Hospitalier Universitaire de Lille, 59000 Lille, France.
ORCID-Profile: Camille Cordier
Förderung
- Associates of Cape Cod Inc
Zitieren
APA
Cordier, C., Lauwerier, N., Faure, E., Poissy, J., Rouzé, A., François, N., Vuotto, F., Loridant, S., Leroy, J., Cornu, M., & Sendid, B. (2025). Performance of Fungitell STAT point-of-care test for the diagnosis of invasive fungal diseases. Medical Mycology. https://doi.org/10.1093/mmy/myaf050
Vancouver
Cordier C, Lauwerier N, Faure E, Poissy J, Rouzé A, François N, et al. Performance of Fungitell STAT point-of-care test for the diagnosis of invasive fungal diseases. Medical Mycology. 2025. doi:10.1093/mmy/myaf050
BibTeX
@article{Cordier2025,
author = {Cordier, Camille and Lauwerier, Nicolas and Faure, Emmanuel and Poissy, Julien and Rouzé, Anahita and François, Nadine and Vuotto, Fanny and Loridant, Séverine and Leroy, Jordan and Cornu, Marjorie and Sendid, Boualem},
title = {Performance of Fungitell STAT point-of-care test for the diagnosis of invasive fungal diseases},
journal = {Medical Mycology},
year = {2025},
doi = {10.1093/mmy/myaf050}
}
EUVIMED